Gan Li

Title: Gan Li: Innovator in Nucleoside Compound Preparation

Introduction

Gan Li is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of nucleoside compounds. His innovative methods have the potential to enhance industrial applications in this area.

Latest Patents

Gan Li holds a patent for a method of preparing a β-nucleoside compound. This method involves a one-pot process that includes several key steps. First, a silylation reaction of a nitrogenous base is performed in the presence of TMSOTf, resulting in a protected nitrogenous base. Next, a direct glycosylation reaction occurs without isolating the reaction liquid, using a five- or six-membered ring saccharide or its derivative. Finally, a deprotection reaction yields the β-nucleoside compound. This method significantly increases the yield of materials in β-configuration and is characterized by its simplicity, energy conservation, and environmental protection.

Career Highlights

Gan Li is currently employed at Jiangsu Aosaikang Pharmaceutical Co., Ltd. His work focuses on developing efficient methods for synthesizing pharmaceutical compounds. His innovative approach has garnered attention in the industry for its practical applications.

Collaborations

Gan Li collaborates with talented coworkers, including Zaiwei Zong and Qian Zhao. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Gan Li's contributions to the preparation of nucleoside compounds exemplify the importance of innovation in pharmaceutical chemistry. His patented method not only enhances efficiency but also aligns with modern sustainability goals.